Memorial Sloan Kettering Cancer Center is a clinical research site located in Long Island City, New York, United States 11101.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Cancer Center has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer, Myelodysplastic Syndromes, Relapsed/Refractory Acute Leukemia.
Sponsors: Pfizer, Agios Pharmaceuticals, Inc., Syndax Pharmaceuticals.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Cancer Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Cancer Center has 5 clinical trials on record, with 1 currently active. Their work covers HR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast Cancer, Myelodysplastic Syndromes, Relapsed/Refractory Acute Leukemia.
Memorial Sloan Kettering Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.